Siwach S B, Dahiya S S, Seth S, Seth R K, Sharma D
Dept. of Med & Biochem, Medical College, Rohtak.
J Assoc Physicians India. 1993 May;41(5):293-4.
Adverse alterations in lipid profile suggesting higher atherogenicity were observed following 12 weeks treatment with atenolol in patients of hypertension. No significant alterations in lipid profile were observed with labetalol therapy.
在高血压患者中,使用阿替洛尔治疗12周后,观察到脂质谱的不良改变,提示动脉粥样硬化性增加。使用拉贝洛尔治疗未观察到脂质谱的显著改变。